Cambridge Capital Group (CCG) offers development funding for early stage technology based companies, primarily in Cambridge, the pre-eminent technology cluster in the UK. Non technology companies are considered occasionally but only if they come recommended by our network of members.

We are a private syndicate of angel investors and have been active since 2001, although the founders have been successful private investors in technology start-ups for the last 10 years.

The founders of Cambridge Capital Group backed Bookham Technology and nCipher in early funding rounds, both of which floated very successfully on the London Stock Exchange in 2000. Recent successes include ITM Power and Bango, both listed on AIM, and DanioLabs, sold to Summit Plc.

2009 CCG Annual Convention - Jesus College, May 21st - sponsored by Merrill Lynch

CCG 2009 Spring Meeting – Clare College, Cambridge

Our first event of 2009 took place on February 26th. We are closing one seed investment from this event.

CCG Autumn Meeting – Kings College, October 9th

Members and sponsors gathered in the prestigious and historic surroundings of Kings College to hear presentations from six carefully screened early-stage technology businesses. Sectors range from software for mobile applications, medical diagnostics and devices, automotive design for electric vehicles, aluminium recycling technology for packaging and electronics for renewable energy generation.Three investments have been closed following this event.

CCG Convention 2008 - Jesus College, Cambridge, May 22nd-23rd.

Recently expanded CCG with five investors joining the group in 2008, sees presentations from 7 carefully screened early-stage companies seeking angel finance. 1-2 will be selected for funding by CCG...A number of portfolio companies also gave presentations of their progress.

Portfolio company name change to SUMMIT PLC (previously VasTox plc): Read more...
DanioLabs Ltd. acquired by VasTox plc, an AIM listed biotech company. DanioLabs was a CCG portfolio company that has merged its zebrafish based biotech business with VasTox (in April 2007), to create a world-leading company in its field.The combined group is now called Summit plc.

DanioLabs Ltd. acquired by VasTox plc, an AIM listed biotech company. DanioLabs was a CCG portfolio company that has merged its zebrafish based biotech business with VasTox (in April 2007), to create a world-leading company in its field.The combined group is now called Summit plc.

Two recent IPO's by portfolio companies gave substantial profitable realisations to CCG members:

Bango achieved a listing on AIM in June 2005, raising £7m at a valuation of £35m.

Bango provides a technology platform as a service to content providers, enabling billing via the mobile phone operators. CCG members invested in the start-up round alongside other Cambridge based seed investors.

ITM Power, floated on AIM in June 2004 raising £10m at a valuation of £40m.

CCG investors backed this fuel cell technology company in 2002, and the potential for its hydrophilic polymer materials in new energy industries has been recognised by a consortium of institutional investors. The share price did extremely wellover the subsequent two years, giving large profits to the angel investors.